Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats

Masafumi Oyama, Kosuke Kaji, Norihisa Nishimura, Junichi Hanatani, Tatsuya Nakatani, Naoki Nishimura, Akihiko Shibamoto, Shohei Asada, Yuki Tsuji, Koh Kitagawa, Shinya Sato, Tadashi Namisaki, Hitoshi Yoshiji

Open source

DOI: 10.3748/wjg.v31.i33.109562
Published: 2025-09-07
Container: World Journal of Gastroenterology
Publisher: Baishideng Publishing Group Inc.
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3748/wjg.v31.i33.109562,
  title = {Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats},
  author = {Masafumi Oyama and Kosuke Kaji and Norihisa Nishimura and Junichi Hanatani and Tatsuya Nakatani and Naoki Nishimura and Akihiko Shibamoto and Shohei Asada and Yuki Tsuji and Koh Kitagawa and Shinya Sato and Tadashi Namisaki and Hitoshi Yoshiji},
  year = {2025},
  journal = {World Journal of Gastroenterology},
  doi = {10.3748/wjg.v31.i33.109562},
  url = {https://doi.org/10.3748/wjg.v31.i33.109562}
}

RIS

TY  - JOUR
TI  - Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats
AU  - Masafumi Oyama
AU  - Kosuke Kaji
AU  - Norihisa Nishimura
AU  - Junichi Hanatani
AU  - Tatsuya Nakatani
AU  - Naoki Nishimura
AU  - Akihiko Shibamoto
AU  - Shohei Asada
AU  - Yuki Tsuji
AU  - Koh Kitagawa
AU  - Shinya Sato
AU  - Tadashi Namisaki
AU  - Hitoshi Yoshiji
PY  - 2025
JO  - World Journal of Gastroenterology
DO  - 10.3748/wjg.v31.i33.109562
UR  - https://doi.org/10.3748/wjg.v31.i33.109562
ER  -

APA

Oyama, M., Kaji, K., Nishimura, N., Hanatani, J., Nakatani, T., Nishimura, N., Shibamoto, A., Asada, S., Tsuji, Y., Kitagawa, K., Sato, S., Namisaki, T., & Yoshiji, H. (2025). Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.v31.i33.109562

Source records

crossref · retrieved 2026-09-26T11:43:27.142Z